Standout Papers

Gemfibrozil for the Secondary Prevention of Coronary Heart ... 1984 2026 1998 2012 2.5k
  1. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol (1999)
    Hanna E. Bloomfield, Sander J. Robins et al. New England Journal of Medicine
  2. Adenocarcinoma and Barrett's esophagus. An overrated risk? (1984)
    Stuart J. Spechler, Alan H. Robbins et al. PubMed
  3. Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events (2001)
    Sander J. Robins, Dorothea Collins et al. JAMA

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 100 standout
Sub-graph 1 of 13

Citing Papers

Frailty in Older Adults
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
1 intermediate paper

Works of Hanna E. Bloomfield being referenced

Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis
2020
Screening Pelvic Examinations in Asymptomatic, Average-Risk Adult Women: An Evidence Report for a Clinical Practice Guideline From the American College of Physicians
2014

Author Peers

Author Last Decade Papers Cites
Hanna E. Bloomfield 4601 2002 3767 81 8.3k
Michael Szarek 3713 2204 3156 120 7.0k
Gérald Luc 3067 2947 2544 87 8.9k
A R Lorimer 5843 2714 3194 111 9.3k
Vesa Manninen 4906 2623 4674 144 11.0k
M. H. Frick 4207 2444 3430 106 8.4k
Charles L. Shear 6238 2404 4080 70 9.5k
James H. McKillop 5050 2000 2474 115 8.6k
Thomas Cole 6222 2625 3498 63 9.5k
Matti Mänttäri 4069 2198 3544 59 8.4k
Dorothea Collins 3337 1410 3229 39 6.1k

All Works

Loading papers...

Rankless by CCL
2026